These data unveiled a novel etiological mechanism of HMGCS2-mediated AECII lipid metabolism in the genesis and development of pulmonary fibrosis and provided a novel target for clinical intervention. The gene discussed is HMGCS2; the disease is pulmonary fibrosis.